Loading...
RSS feeds allow Web site content to be gathered via feed reader software. Click the subscribe link to obtain the feed URL for this page. The feed will update when new content appears on this page.
Highlights

A collection of news and information related to Amgen Inc. published by this site and its partners.

Sort By: Relevancy | Date | Type
Displaying items 1-12 of 133
» View wsbt.com items only
    May 17, 2013 |Story| Reuters
  1. U.S. RESEARCH ROUNDUP: Visa, Wal-Mart, Biogen Idec, Walt Disney

    Reuters
    May 17 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S. companies, including Macy's and Biogen Idec on Friday. HIGHLIGHTS * Aruba Networks : FBN, JP Morgan, Needham, Wedbush, Wells Fargo cut rating *...

    Tags: Ratings, Triumph Group Inc., Gilead Sciences Inc., United Rentals Incorporated, PPG Industries Incorporated

  2. May 16, 2013 |Story| Reuters
  3. Warning didn't change for-profit dialysis drug use

    Reuters
    NEW YORK (Reuters Health) - Despite a strong warning from U.S. regulators in 2007, for-profit dialysis centers still gave their kidney failure patients more of a certain anemia drug than non-profit centers in 2008, says a new study. The researchers write...

    Tags: Renal Failure, Medical Research, Death, Science and Technology, Heart Disease

  4. May 12, 2013 |Story| Los Angeles Times
  5. Lieuwe Westra wins Amgen Tour's first stage under brutal heat

    ESCONDIDO, Calif. — Lieuwe Westra, red-faced and shaking, was the winner of Sunday's first stage at the Amgen Tour of California, on a day when temperatures on the route were recorded as high as 105 degrees.
    ESCONDIDO, Calif. — Lieuwe Westra, red-faced and shaking, was the winner of Sunday's first stage at the Amgen Tour of California, on a day when temperatures on the route were recorded as high as 105 degrees. James Stemper, of the 5-hour Energy/...

    Tags: Peter Sagan, Lieuwe Westra, Tour of California

  6. May 12, 2013 |Story| Los Angeles Times
  7. Bill would regulate 'biosimilar' drugs

    SACRAMENTO — Two of the nation's largest biotech companies — Amgen Inc. of Thousand Oaks and Genentech Inc. of South San Francisco — are fighting in Sacramento to keep a tight grip on some of their most lucrative drugs.
    SACRAMENTO — Two of the nation's largest biotech companies — Amgen Inc. of Thousand Oaks and Genentech Inc. of South San Francisco — are fighting in Sacramento to keep a tight grip on some of their most lucrative drugs. At stake is a...

    Tags: Jerry Hill, Pharmaceuticals, Roche Holding AG, Viral Diseases and Infections, Imports

  8. May 6, 2013 |Story| Los Angeles Times
  9. Amgen at a glance

    The company: Amgen Inc. Headquarters: Thousand Oaks Ticker: AMGN Employees: 18,000 Leadership: Robert A. Bradway, chief executive since May 2012 2012 revenue: $17.3 billion 2012 net income: $4.3 billion Stock price: $106.48 at Friday's close...
  10. May 6, 2013 |Story| Los Angeles Times
  11. Amgen aims to restock its medicine cabinet

    Amgen Inc. is a biotechnology company that develops medicines used in the treatment of cancer, kidney disease, arthritis, bone disease and other serious illnesses.
    Amgen Inc. is a biotechnology company that develops medicines used in the treatment of cancer, kidney disease, arthritis, bone disease and other serious illnesses. The Thousand Oaks company's top-selling products include arthritis medication Enbrel,...

    Tags: Drugs and Medicines, Osteoporosis, Kidney Disease, Chemotherapy, Enbrel (drug)

  12. May 5, 2013 |Story| Los Angeles Times
  13. A wife's Alzheimer's, a husband's obsession

    Ken Chiate is a born problem-solver, and in the summer of 1961, when he was on break from college, his problem was a head-turning blond named Jeannette.
    Ken Chiate is a born problem-solver, and in the summer of 1961, when he was on break from college, his problem was a head-turning blond named Jeannette. He was head lifeguard at a public pool in Phoenix, where his father owned a liquor store. She worked...

    Tags: Parkinson's Disease, Justice System, Enbrel (drug), Arthritis, Medical Research

  14. May 3, 2013 |Story| Reuters
  15. Big drugmakers think small with nanomedicine deals

    Reuters
    * Nanomedicine promises greater precision and monitoring * Pfizer, Amgen, AstraZeneca among firms placing bets * Early-stage research but scientists see momentum building By Ben Hirschler LONDON, May 3 (Reuters) - Is nanomedicine the next big thing? A...

    Tags: Preventative Medicine, Colleges and Universities, Oncology, Medical Research, AstraZeneca Plc

  16. May 1, 2013 |Story| Reuters
  17. U.S. RESEARCH ROUNDUP: Berkshire, Fortinet, Aetna, NextEra Energy

    Reuters
    May 1 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S. companies including Berkshire Hathaway, Aetna and Fortinet Inc on Wednesday. HIGHLIGHTS * Aetna Inc : Credit Suisse, Jefferies, Susquehanna, others...

    Tags: Oil States International Incorporated, Sourcefire, Inc., Goldman Sachs Group, Inc., Entertainment, Garmin Ltd.

  18. May 1, 2013 |Story| Reuters
  19. Drugs from Amgen, others assessed by FDA as radiation treatments

    Reuters
    May 1 (Reuters) - Drugs from Amgen Inc, Teva Pharmaceutical Industries and Sanofi that boost white blood cells are being evaluated by U.S. regulators as treatments for radiation exposure caused by a nuclear attack or accident. The drugs, known as...

    Tags: Chemotherapy, National Institutes of Health, Health Organizations, Science and Technology, Health Treatments

  20. Apr 29, 2013 |Story| Aberdeen News
  21. LETTER: ALEC too far right for these groups

     The American Legislative Exchange Council (ALEC) is a group promoting far-right legislation. Its tax exempt status is currently challenged, as its sole purpose is to formulate legislation promoting extremely conservative points of view and helping the...

    Tags: Reckitt Benckiser, Agriculture, Entergy Corporation, Coca-Cola Co., Environmental Issues

  22. Apr 26, 2013 |Story| Los Angeles Times
  23. L.A. jury finds three guilty in $1.5-million Medicare fraud scheme

    A federal jury in Los Angeles found an Anaheim physician and two others guilty this week for their roles in a $1.5-million Medicare fraud scheme involving power wheelchairs. At trial, federal prosecutors said that Godwin Onyeabor, 49, an officer at...

    Tags: U.S. Department of Health and Human Services, Drugs and Medicines, Justice System, Medicare, Trials

 1  2 3 4 5 6 7 8 9 10 11-12Next >
Original site for Amgen Inc. topic gallery.
Loading...
 
 

Date:

Credit:

User-submitted

Tags:

Rate:
Sending...

E-mail this photo

Error: malformed email address(es)
Both "from" and "recipient" email fields are required.

Recipient E-mail Addresses

(up to 3, separated by commas) Send me a copy.

From:

e-mail | buy this photo | link to photo
Amgen Inc. Photos
Some firms seek to make "biosimilar" drugs that would p...
(April 25, 2013)
Bill would regulate ‘biosimilar’ drugs
, Rathmann was the Thousand Oaks firm's first chief exe...
(April 25, 2012)
George B. Rathmann
Davies, 50, brings to Hospira more than 20 years of str...
(January 31, 2012)
Richard Davies, chief commercial officer, Hospira